---
audienceLevel: patient
cancerTypes:
- general
citation: NCI, 2025
language: en
lastReviewed: '2025-12-30'
license: public_domain
reviewFrequency: quarterly
source: NCI
sourceType: 02_nci_core
status: active
tags:
- treatment
title: BuMel - NCI
url: https://www.cancer.gov/about-cancer/treatment/drugs/bumel
version: v1
---

# BuMel - NCI

# BuMel

Placeholder slot

This chemotherapy combination contains the drugs busulfan and melphalan hydrochloride. Combinations usually work better than single drugs because
different drugs kill
cancer
cells in different ways.

Drugs in the BuMel combination:

|  |  |
| --- | --- |
| **Bu** | = [Busulfan](/about-cancer/treatment/drugs/busulfan) |
| **Mel** | = [Melphalan Hydrochloride](/about-cancer/treatment/drugs/melphalan-hydrochloride) |

Each of the drugs in this combination is approved by the
[Food and Drug
Administration (FDA)](/Common/PopUps/popDefinition.aspx?id=454785&version=Patient&language=English)
to treat cancer or conditions related to cancer.

## Use in Cancer

BuMel
is used to treat:

- **[Neuroblastoma](/Common/PopUps/popDefinition.aspx?id=45418&version=Patient&language=English)** that is [high risk](/Common/PopUps/popDefinition.aspx?id=45079&version=Patient&language=English). It is used to prepare patients for a [stem cell transplant](/Common/PopUps/popDefinition.aspx?id=46695&version=Patient&language=English).

This combination may also be used with other drugs or
treatments or to treat other types of cancer.

## More About BuMel

[Definition from the NCI Drug Dictionary](https://www.cancer.gov/publications/dictionaries/cancer-drug/def/780869) - Detailed scientific definition and other names for this drug.
